trial

Reward Processing in Mental Illness

NCTId NCT03068793
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 80 (actual)
Sponsored by Susanna Fryer
Primary completion 2019-06-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
80 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2013-10-01
Primary completion
2019-06-30
Eligibility
ALL · 18 Years · 30 Years

Interventions & indications

Drugs
Electroencephalography (EEG) and Magnetic Resonance Imaging (MRI)

Sponsors

Susanna FryerLead Sponsor

Investigators

1
Susanna Fryer, PhDPrincipal Investigator

Sites

1 total
San Francisco, United States

Facts & assertions

4 sourced
Enrollment
80
Phase
NA
Primary Completion Date
2019-06-30
Status
COMPLETED
relationships
The graph out of here
drug
Electroencephalography (EEG) and Magnetic Resonance Imaging (MRI)
drug
lead_sponsor
Susanna Fryer
company
indication
Early-onset Schizophrenia
indication
investigator
Susanna Fryer, PhD
person